A lentivirus vector and its construction method and application

CN121826065BActive Publication Date: 2026-08-28SHENZHEN ZHUOQIAO MEDICAL HEALTH TECHNOLOGY CO LTD
View PDF 2 Cites 0 Cited by

Patent Information

Application Number
CN202512050893.1
Authority / Receiving Office
CN · China
Patent Type
Patents(China)
Current Assignee / Owner
Filing Date
2025-12-31
Publication Date
2026-08-28
Estimated Expiration
2045-12-31

AI Technical Summary

Technical Problem

[0006]本发明的目的是为了克服VSV-G包膜病毒存在较高免疫原性、在血清中的稳定性较差的问题,提供一种慢病毒载体及其构建方法和应用

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN121826065B_ABST
    Figure CN121826065B_ABST
Patent Text Reader

Abstract

The application relates to the field of biological medicine, and discloses a lentivirus vector and a construction method and application thereof, the lentivirus vector comprising: (1) an antigen-targeting artificial protein receptor, the receptor comprising a target cell surface antigen binding domain and a transmembrane domain; (2) a mutated Marabavirus envelope protein; and (3) an expression cassette, the expression cassette comprising a heterologous transgene. The new lentivirus vector based on the mutated Marabavirus envelope provided by the application can realize specific infection of target cells in vitro and in vivo. Compared with a vesicular stomatitis virus envelope VSV-G, the lentivirus vector constructed based on the mutated Marabavirus envelope protein has better stability in serum, higher efficiency of specific infection of target cells, and more prominent drug efficacy in a mouse tumor model.
Need to check novelty before this filing date? Find Prior Art

Citation Information

Patent Citations

  • In VIVO lentivirus animal models

    WO2024207008A2

  • Mutated vesicular virus envelope protein and use thereof in lentiviral vector packaging

    WO2025247369A1